The Drug Effectiveness Review Project (DERP) was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations was formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. From 2003 to 2018, the Pacific Northwest Evidence-based Practice Center (EPC) supported the project by developing its methods and processes for, and conducting, systematic reviews on drug topics. The reviews adhered to high standards for comparative effectiveness reviews, as established by the Agency for Healthcare Research and Quality's EPC program, and were tailored for the unique needs of DERP. Our EPC researchers had direct, regular communication with policy-makers at participating Medicaid agencies and the reports had direct impact on policy and decision-making. The Project innovated methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers while maximizing efficiency.

The citations for the systematic reviews conducted by the Pacific Northwest EPC for DERP are listed below, according the 3-year time frame in which they were conducted (DERP I, II, III, IV or V).  Full versions of the reports conducted from 2003 to 2009 (DERP I – III) are available through the links provided here.  Reports conducted from 2010 to 2018 (DERP IV and V) are available through membership in the DERP project. Please contact the Center for Evidence-based Policy, which manages the project, for more information.

DERP V  -  DERP IV  -  DERP III  -  DERP II  -  DERP I

DERP Methods Papers

McDonagh MS, Thakurta S, Peterson K. A study of the value of requesting information from drug manufacturers for systematic reviews; 9 years of experience from the drug effectiveness review project. Systematic Reviews, 2018, 7:172. doi: 10.1186/s13643-018-0834-2. PMID: 30348228.

McDonagh, MS, Jonas DE, Gartlehner G, Little A, Peterson K, Carson S, Gibson M, Helfand, M. Methods for the Drug Effectiveness Review Project. BMC Med Res Methodol, 2012, 12(1):140. doi: 10.1186/1471-2288-12-140. PMID: 22970848.

McDonagh MS, Peterson K, Balshem H, Helfand M. US Food and Drug Administration documents can provide unpublished evidence relevant to systematic reviews. J Clin Epidemiol, 2013, 66(10):1071-81. doi: 10.1016/j.jclinepi.2013.05.006. PMID: 23856190.

Peterson K, McDonagh MS, Fu R. Decisions to update comparative drug effectiveness reviews vary based on type of new evidence. J Clin Epidemiol, 2011, 64(9):977-84. doi: 10.1016/j.jclinepi.2010.11.019. PMID: 21411283.

Thaler KJ, Morgan LC, Van Noord M, Jonas DE, McDonagh MS, Peterson K, Glechner A, Gartlehner G. A case study of pooled-studies publications indicated potential for both valuable information and bias. J Clin Epidemiol, 2013, 66(10):1082–1092. doi: 10.1016/j.jclinepi.2013.05.002. PMID: 23850407. 

Cohen AM, Ambert K, McDonagh M. Studying the potential impact of automated document classification on scheduling a systematic review update. BMC Medical Informatics and Decision Making, 2012, 12:33. doi: 10.1186/1472-6947-12-33. PMID: 22515596.

Cohen AM, Ambert K, McDonagh M. Cross-topic learning for work prioritization in systematic review creation and update. J Am Med Inform Assoc, 2009 Sep-Oct; 16(5):690-704. doi: 10.1197/jamia.M3162. PMID: 19567792.

McDonagh M, Holmes R, Lazur BH, Crabtree E. Long-Acting Insulins for Type 1 and Type 2 Diabetes. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2017. Available with membership in the Drug Effectiveness Review Project.

Gartlehner G, Wagner G, Schultes M, Titscher V, Teufer B, Klerings I. Second-generation Antidepressants: Levomilnacipran, Vilazodone, and Vortioxetine Compared with Other Second-generation Antidepressants. Targeted Update Final Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2017. Available with membership in the Drug Effectiveness Review Project.

McDonagh M, Crabtree E, Stoner R. Benzodiazepines. Final Summary Review prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2017. Available with membership in the Drug Effectiveness Review Project.

McDonagh M, Selph S, Blazina I, Holmes R, Holzhammer B, Stoner R, LaLonde L, Fu R. Second-Generation Antipsychotic Drugs. Final Update 5 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2016. Available with membership in the Drug Effectiveness Review Project.

Selph S, Blazina I, Holzhammer B. Cardiovascular Harms of Newer Diabetes Medications and Combinations. Supplement prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2016. Available with membership in the Drug Effectiveness Review Project.

Selph S, Blazina I, Guttmann-Bauman I, Holzhammer B. Newer Diabetes Medications and Combinations. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2016. Available with membership in the Drug Effectiveness Review Project.

McDonagh M, Holmes R, Blazina I, Holzhammer B, Thompson M. Drugs to Treat Asthma and Chronic Obstructive Pulmonary Disease (COPD). Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2016. Available with membership in the Drug Effectiveness Review Project.

Gartlehner G, Glechner A, Kien C, Mahlknecht P, Mesgarpour B, Thaler K. Targeted Immune Modulators. Final Update 5 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2016. Available with membership in the Drug Effectiveness Review Project.
Abstract

Selph S, Holmes R,Thakurta S, Griffin J, McDonagh M. Disease-modifying Drugs for Multiple Sclerosis. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2016. Available with membership in the Drug Effectiveness Review Project.

McDonagh M, Blazina I, Holzhammer B. Newer Oral Anticoagulant Drugs. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2016. Available with membership in the Drug Effectiveness Review Project.

Selph S, Holmes R, Thakurta S, Griffin J. Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection. Final Streamlined Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2016. Available with membership in the Drug Effectiveness Review Project.

[ Back to top ]

McDonagh M, Holmes R, Lazur BH, Crabtree E. Long-Acting Insulins for Type 1 and Type 2 Diabetes. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2017. Available with membership in the Drug Effectiveness Review Project.

Holmes R, Holzhammer B, McDonagh M. Long-Acting Insulins for Type 1 and Type 2 Diabetes. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2015. Available with membership in the Drug Effectiveness Review Project.

Selph S, Holmes R, Holzhammer B. Long-acting Opioid Analgesics. Final Streamlined Update 7 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, August 2015. Available with membership in the Drug Effectiveness Review Project.

Peterson K, Holzhammer B, McDonagh M. Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) Inhibitors. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2015. Available with membership in the Drug Effectiveness Review Project.

McDonagh M, Peterson K, Holzhammer B. Pharmacologic Treatments in ADHD. Final Update 5 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2015. Available with membership in the Drug Effectiveness Review Project.

Selph S, Holmes R, Holzhammer B. Direct-acting Antiviral Agents for Chronic Hepatitis C Infection. Final Streamlined Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2015. Available with membership in the Drug Effectiveness Review Project.

Selph S, Holmes R, Holzhammer B, McDonagh M. Comparative Effectiveness of Direct-acting Antiviral Agents for Hepatitis C Infection. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2015. Available with membership in the Drug Effectiveness Review Project.

Peterson K, Holmes R, Selph S, Holzhammer B, McDonagh M. Comparative Effectiveness of Direct-acting Antiviral Agents for Hepatitis C Infection. Final Summary Review prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2014. Available with membership in the Drug Effectiveness Review Project.

Feltner C, Wines R, Simon J, Rowe C, Posey R, Jonas D. Newer Diabetes Medications and Combinations. Final Streamlined Update 1 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2014. Available with membership in the Drug Effectiveness Review Project.

Thaler K, Mahlknecht P, Glechner A, Mazinanian A, Mesgarpour B, Gartlehner G. Targeted Immune Modulators. Final Update 4 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2014. Available with membership in the Drug Effectiveness Review Project.

Selph S, Holmes R, Peterson K, Thakurta S, Holzhammer B, Stoner R, McDonagh M. Drugs to Treat Asthma and Chronic Obstructive Pulmonary Disease (COPD). Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2014. Available with membership in the Drug Effectiveness Review Project.

McDonagh M, Peterson K, Fu R, Thakurta S, Griffin J. Second Generation Antipsychotic Drugs. Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2013. Available with membership in the Drug Effectiveness Review Project.
Report
Evidence Tables

Selph S, Thakurta S, McDonagh M. Disease-modifying Drugs for Multiple Sclerosis. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2013. Available with membership in the Drug Effectiveness Review Project.

Selph S, Carson S, McDonagh M. Overactive Bladder Drugs. Final Summary Review prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2013. Available with membership in the Drug Effectiveness Review Project.

Carson S, Selph S, Thakurta S, McDonagh M. Newer Oral Anticoagulant Drugs. Final Summary Review prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2013. Available with membership in the Drug Effectiveness Review Project.

Feltner C, Wines R, Posey R, Jonas D. Newer Diabetes Medications, TZDs, and Combinations. Single Drug Addendum: Linagliptin. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2012. Available with membership in the Drug Effectiveness Review Project.

[ Back to top ]

Thaler K, Gartlehner G, Kien C, Van Noord M, Thakurta S, Wines R, Hansen R, McDonagh M. Targeted Immune Modulators. Final Update 3 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, March 2012.
Report
Evidence Tables

McDonagh M, Peterson K, Thakurta S, Low A. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder. Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2011.
Report
Evidence Tables

Carson S, Thakurta S, Low A, Smith B, Chou R. Long-Acting Opioid Analgesics. Final Update 6 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2011.
Report
Evidence Tables

Ketchum K, Peterson K, Thakurta S, Low A, McDonagh M. Newer Antiplatelet Agents. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2011.
Report
Evidence Tables

Selph S, Carson S, Fu R, Thakurta S, Low A, McDonagh M. Neuropathic Pain. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2011.
Report
Evidence Tables

Jonas D, Wines R, DelMonte M, Amick H, Wilkins T, Einerson B, Schuler C, Wynia B, Shilliday B. Controller Medications for Asthma. Final Update 1 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2011.
Report
Evidence Tables

Smith B, Peterson K, Fu R, Thakurta S, Low A, McDonagh M. Drugs for Fibromyalgia. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2011.
Report
Evidence Tables

Gartlehner G, Hansen R, Reichenpfader U, Kaminski A, Kien C, Strobelberger M, Van Noord M, Thieda P, Thaler K, Gaynes B. Second-generation Antidepressants. Final Update 5 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, March 2011.
Report
Evidence Tables

Jonas D, Van Scoyoc E, Gerrald K, Wines R, Amick H, Triplette M, Runge T. Newer Diabetes Medications, TZDs, and Combinations. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2011.
Report
Evidence Tables

McDonagh M. Disease-modifying Drugs for Multiple Sclerosis. Single Drug Addendum: Fingolimod. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2011.
Report
Evidence Tables

Peterson K, McDonagh M, Thakurta S, Dana T, Roberts C, Chou R, Helfand M. Nonsteroidal Antiinflammatory Drugs (NSAIDs). Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2010.
Report
Evidence Tables

Smith B, Carson S, Fu R, McDonagh M, Dana T, Chan B, Thakurta S, Gibler A. Disease-modifying Drugs for Multiple Sclerosis. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, August 2010.
Report
Evidence Tables

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S. Atypical Antipsychotic Drugs. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2010.
Report
Evidence Tables

Carson S, Lee N, Thakurta S. Newer Antihistamines. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2010.
Report
Evidence Tables

[ Back to top ]

Norris S, Weinstein J, Peterson K, Thakurta S. Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotension II Receptor Blockers. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2010.
Report
Evidence Tables

Smith B, Lee N, Haney E, Carson, S. HMG-CoA Reductase Inhibitors (statins) and Fixed-dose combination products containing a statin. Final Update 5 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2009.
Report
Evidence Tables

Gartlehner G, Thieda P, Morgan L, Thaler K, Hansen R, Jonas B. Targeted Immune Modulators. Final Update 2 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2009.
Report

McDonagh M, Christensen V, Peterson K, Thakurta S. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2009.
Report

Helfand M, Peterson K, Christensen V, Dana T, Thakurta S. Beta Adrenergic Blockers. Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2009.
Report
Evidence Tables

Helfand M, Peterson K. Triptans. Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2009.
Report
Evidence Tables

McDonagh M, Carson S, Thakurta S. Proton Pump Inhibitors. Final Update 5 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2009.
Report
Evidence Tables

McDouagh M, Selover D, Santa J, Thakurta S. Agents for Overactive Bladder. Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, March 2009.
Report
Evidence Tables

Peterson K, McDonagh M, Carson S, Thakurta S. Newer Antiemetics. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2009.
Report
Evidence Tables

Jonas D, Kiser K, Wines R, Shilliday B, Morgan L, Thieda P, Reuland D. Controller Medications for Asthma. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2008.
Report
Evidence Tables

McDonagh M, Peterson K, Lee N, Thakurta S. Antiepileptic Drugs for Indications Other Than Epilepsy. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2008.
Report
Evidence Tables

Gartlehner G, Morgan L, Thieda P, Thaler K, Hansen R, Gaynes B, Lohr K, Carey T. Second Generation Antidepressants. Final Update 4 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2008.
Report
Evidence Tables

Carson S, McDonagh M, Thakurta S, Yen P. Newer Drugs for Insomnia. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2008.
Report
Evidence Tables

Norris S, McNally T, Thakurta, S. Quick-relief Medications for Asthma. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2008.
Report
Evidence Tables

[ Back to top ]

Lee N, McDonagh M, Chan B, Peterson K, Thakurta S. Topical Calcineurin Inhibitors. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2008.
Report
Evidence Tables

Norris S, Carson S, Thakurta S, Chan B. Thiazolidinediones. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, August/September 2008.
Report
Evidence Tables

Norris S, Lee N, Severance S, Thakurta S, Chan B. Newer Drugs for the Treatment of Diabetes Mellitus. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, August 2008.
Report
Evidence Tables

Selover D, Dana T, Smith C, Peterson K. Nasal Corticosteroids. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2008.
Report
Evidence Tables

Peterson K, Carson S, Chan B, Thakurta S. Atypical Antipsychotic Drugs. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2008.
Report
Evidence Tables

Chou R, Carson S. Long-Acting Opioid Analgesics. Final Update 5 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2008.
Report
Evidence Tables

McDonagh M, Peterson K, Dana T, Thakurta S. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2007.
Report
Evidence Tables

McDonagh M, Peterson K, Thakurta S, Dana T. Fixed Dose Combination Drug Products for the Treatment of Type 2 Diabetes and Hyperlipidemia. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2007.
Report
Evidence Tables

Helfand M, Peterson K, Dana T. Beta Adrenergic Blockers. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2007.
Report
Evidence Tables

Nelson H, Nygren P, Freeman M, Chan B. Hormone Therapy for Postmenopausal Woman or Women in the Menopausal Transition Stage. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2007.
Report
Evidence Tables

Chou R, Norris S, Peterson K, Chan B. Drugs for Neuropathic Pain. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, October 2007.
Report
Evidence Tables

Gartlehner G, Jonas D, Morgan L, Ringel Y, Hansen R, Bryant C, Carey T. Constipation Drugs. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2007.
Report and Evidence Tables

Selover D, Smith C, Peterson K. Nasal Corticosteroids. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2006.
Report
Evidence Tables

[ Back to top ]

McDonagh M, Dana T, Chan B, Thakurta S, Gibler A. Disease-modifying drugs for Multiple Sclerosis. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2007.
Report
Evidence Tables

Chou R, Carson S, Chan B, Care B. Pegylated Interferons for Chronic Hepatitis C Infection. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2007.
Report
Evidence Tables

Dailey J, Glassman P, Suttorp M, Chen S. Newer Antiplatelet Agents. Final Update 1 Report prepared by the Southern California Evidence-based Practice Center RAND for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2007.
Report
Evidence Tables

Gartlehner G, Hansen R, Theida P, Jonas B, Lohr K, Carey T. Targeted Immune Modulators. Final Update 1 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2007.
Report
Evidence Tables

Norris S, Yen P, Dana T, Care B, Burda B. Beta2-Agonists. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2006.
Report
Evidence Tables

Chou R, Helfand M, Peterson K, Dana T, Roberts C. Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs). Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2006.
Report
Evidence Tables

Gartlehner G, Hansen R, Kahwati L, Lohr K, Gaynes B, Carey T. Second Generation Antidepressants. Final Update 3 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2006.
Report and Evidence Tables

Helfand M, Carson S, Kelley C. HMG-CoA Reductase Inhibitors (Statins). Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, August 2006.
Report
Evidence Tables

Carson S, Yen P, McDonagh M. Newer Drugs for Insomnia. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2006.
Report
Evidence Tables

McDonagh M, Carson S. Proton Pump Inhibitors. Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2006.
Report
Evidence Tables

Hansen R, Gartlehner G, Kaufer D, Lohr K, Carey T. Alzheimer's Drugs. Final Update 1 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2006.
Report and Evidence Tables

McDonagh M, Peterson K. Pharmacologic Treatments for ADHD. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2006.
Report
Evidence Tables

Goodman F, Glassman P, Ma Q, Maglione M, Rhodes S, Rolon C, Suttorp, M. Antiepileptic Drugs in Bipolar Mood Disorder, Neuropathic Pain, and Fibromyalgia. Final Update 1 Report prepared by the Southern California Evidence-based Practice Center RAND for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2006.
Report
Evidence Tables

Norris S, Carson S, Roberts C. Thiazolidinediones. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2006.
Report
Evidence Tables

[ Back to top ]

Helfand M. Newer Antihistamines. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2006.
Report
Evidence Tables

Chou R. Long-Acting Opioid Analgesics. Final Update 4 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2006.
Report and Evidence Tables

McDonagh M, Peterson K, Freeman M, Carson S. Atypical Antipsychotic Drugs. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2006.
Report
Evidence Tables

Gartlehner G, Hansen R, Kahwati L, Lohr K, Gaynes B, Carey T. Second Generation Antidepressants. Final Update 2 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, March 2006.
Report and Evidence Tables

Furmaga E, Glassman P, Rhodes S, Suttorp M, Mojica W. Angiotensin II Receptor Antagonists. Final Update 1 Report prepared by the Southern California Evidence-based Practice Center RAND for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2006.
Report
Evidence Tables

Peterson K, McDonagh M, Carson S, Lopez S. Newer Antiemetics. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2006.
Report
Evidence Tables

Hansen R, Gartlehner G, Lohr K, Carson S, Carey T. Inhaled Corticosteroids. Final Update 1 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2006.
Report and Evidence Tables

McDonagh M, Selover D, Santa J, Lopez S. Agents for Overactive Bladder. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2005.
Report and Evidence Tables

Carson S, Yen P, McDonagh M. Newer Sedative Hypnotics. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2005.
Report
Evidence Tables

Gartlehner G, Hansen R, Theida P, Jonas B, Lohr K, Carey T. Targeted Immune Modulators. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2005.
Report and Evidence Tables

Dailey J, Glassman P, Suttorp M, Rolon C. Newer Antiplatelet Agents. Final Original Report prepared by the Southern California Evidence-based Practice Center RAND for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2005.
Report and Evidence Tables

Helfand M, Peterson K. Triptans. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2005.
Report and Evidence Tables

McDonagh M, Peterson K. Pharmacologic Treatments for ADHD. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2005.
Report
Evidence Tables

Helfand M, Carson S, Kelley C. HMG-CoA Reductase Inhibitors (Statins). Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2005.
Report and Evidence Tables

[ Back to top ]

Gartlehner G, Hansen R, Kahwati L, Lohr K, Gaynes B, Carey T. Second Generation Antidepressants. Final Update 1 Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2005.
Report and Evidence Tables

Chou R, Helfand M, Carson S. Angiotensin Converting Enzyme Inhibitors. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2005.
Report and Evidence Tables

Helfand M, Peterson K. Beta Adrenergic Blockers. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2005.
Report and Evidence Tables

Chandler C, Chou R, Helfand M. Oral Hypoglycemics. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2005.
Report and Evidence Tables

McDonagh M, Santa J. Agents for Overactive Bladder. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2005.
Report and Evidence Tables

McDonagh M, Carson S. Proton Pump Inhibitors. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2005.
Report and Evidence Tables

Chou R, Peterson K. Skeletal Muscle Relaxants. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2005.
Report and Evidence Tables

Hansen R, Gartlehner G, Kaufer D, Lohr K, Randolph L, Carey T. Alzheimer's Drugs. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2005.
Report and Evidence Tables

Chou R. Long-Acting Opioid Analgesics. Final Update 3 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2005.
Report and Evidence Tables

McDonagh M, Eden K, Peterson K. Calcium Channel Blockers. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, March 2005.
Report
Evidence Tables

McDonagh M, Peterson K, Freeman M, Carson S. Atypical Antipsychotic Drugs. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2005.
Report and Evidence Tables

Hansen R, Gartlehner G, Lohr K, Carson S, Carey T. Inhaled Corticosteroids. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2005.
Report and Evidence Tables

Goodman F, Glassman P, Ma Q, Maglione M, Rhodes S, Rolon C, Suttorp, M. Antiepileptic Drugs in Bipolar Mood Disorder and Neuropathic Pain. Final Original Report prepared by the Southern California Evidence-based Practice Center RAND for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2004.
Report and Evidence Tables

Gartlehner G, Hansen R, Kahwati L, Lohr K, Gaynes B, Carey T. Second Generation Antidepressants. Final Original Report prepared by the RTI-UNC Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2004.
Report and Evidence Tables

[ Back to top ]

Chandler C. Second Generation Antihistamines. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2004.
Report and Evidence Tables

Helfand M, Peterson K. Beta Adrenergic Blockers. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2004.
Report
Evidence Tables

Furmaga E, Glassman P, Rhodes S. Angiotensin II Receptor Antagonists. Final Original Report prepared by the Southern California Evidence-based Practice Center RAND for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2004.
Report and Evidence Tables

Helfand M, Peterson K. Triptans. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2004.
Report and Evidence Tables

Nelson H, Nygren P, Freeman M, Chan B. Estrogen Preparations. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2004.
Report and Evidence Tables

Chou R, Helfand M, Carson S. Angiotensin Converting Enzyme Inhibitors. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2004.
Report and Evidence Tables

McDonagh M, Eden K, Peterson K. Calcium Channel Blockers. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2004.
Report and Evidence Tables

Helfand M, Carson S, Kelley C. HMG-CoA Reductase Inhibitors (Statins). Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, June 2004.
Report and Evidence Tables

Helfand M, Peterson K. Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs). Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, May 2004.
Report and Evidence Tables

McDonagh M, Carson S. Proton Pump Inhibitors. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2004.
Report and Evidence Tables

Chou R. Long-Acting Opioid Analgesics. Final Update 2 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2004.
Report and Evidence Tables

Chandler C, Helfand M. Oral Hypoglycemics. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2004.
Report and Evidence Tables

McDonagh M. Urinary Incontinence Drugs. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2004.
Report and Evidence Tables

Chou R, Peterson K. Skeletal Muscle Relaxants. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, January 2004.
Report and Evidence Tables

Helfand M, Peterson K. Triptans. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, December 2003.
Report and Evidence Tables

[ Back to top ]

Nelson H, Nygren P, Chan B. Estrogen Preparations. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2003.
Report and Evidence Tables

Peterson K, Helfand M. Beta Adrenergic Blockers. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2003.
Report
Evidence Tables

McDonagh M, Eden K, Peterson K. Calcium Channel Blockers. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2003.
Report
Evidence Tables

Helfand M. Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs). Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2003.
Report and Evidence Tables

Chou R, Clark E. Long-Acting Opioid Analgesics for Chronic Non-Cancer Pain. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, September 2003.
Report and Evidence Tables

Kelley C, Helfand M. HMG-CoA Reductase Inhibitors (Statins). Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, July 2003.
Report and Evidence Tables

McDonagh M, Carson S. Proton Pump Inhibitors. Final Update 1 Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2003.
Report and Evidence Tables

Chou R, Peterson K. Skeletal Muscle Relaxants for Spasticity and Musculoskeletal Conditions. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, April 2003.
Report
Evidence Tables

Chandler C, Helfand M. Oral Hypoglycemics. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, March 2003.
Report and Evidence Tables

Helfand M, Peterson K. Triptans. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, March 2003.
Report

Nelson H, Nygren P, Chan B. Estrogen for Treatment of Menopausal Symptoms and Prevention of Low Bone Density & Fractures. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2003.
Report

McDonagh M. Urinary Incontinence Drugs. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, February 2003.
Report and Evidence Tables

Chou R, Clark E. Long-Acting Opioid Analgesics for Chronic Non-Cancer Pain. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2002.
Report

McDonagh M, Carson S. Proton Pump Inhibitors. Final Original Report prepared by the Pacific Northwest Evidence-based Practice Center for the Drug Effectiveness Review Project. Oregon Health & Science University, Portland, Oregon, November 2002.
Report
Evidence Tables

[ Back to top ]